Nanostring Tech

NASDAQ:NSTG   3:59PM EDT
22.58
-0.20 (-0.88%)
StockTwits Share  Twitter Share  Facebook Share

Search For a Symbol

Market Cap (Intraday)800.22M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats...
Estimates Current Quarter
Revenue$28.06 Million
Adjusted EPS-$0.54
See more estimates...
10-Day MA$22.71
50-Day MA$26.75
200-Day MA$24.54
See more pivots...

NanoString Technologies Inc Stock, NASDAQ:NSTG

530 FAIRVIEW AVENUE NORTH, SEATTLE, WA 98109
United States of America
Phone: 206-378-6266
Number of Employees: 407

Description

NanoString Technologies, Inc. develops, manufactures, and sells life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include nCounter Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer pathways gene expression panels, including pathways, immune profiling, and progression panels, as well as nCounter Vantage 3D, other gene expression, miRNA expression, and cancer copy number variation panels. Further, the company offers nCounter Elements reagents that allow users to design customized assays for gene expression, copy number variation, and gene fusions; Master Kits, which include ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It markets its systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories, as well as to clinical laboratories and medical centers. NanoString Technologies, Inc. has collaboration with Celgene Corporation; Merck Sharp & Dohme Corp.; Medivation, Inc.; and Astellas Pharma, Inc. The company was founded in 2003 and is headquartered in Seattle, Washington.